Home » Topics » BioWorld Science

BioWorld Science
RSS

Novartis patents new antimalarials

May 12, 2021

BIRKI, a novel ROCK inhibitor as potential new therapy for diabetic retinopathy

May 12, 2021

S-540956 shows potent in vivo activity as adjuvant for cancer peptide vaccine

May 12, 2021

Foghorn Therapeutics announces FDA clearance of its IND applications

May 12, 2021

Positive data presented from MAD phase I study of CTI-1601 in Friedreich's ataxia

May 12, 2021

FDA clears IND for icapamespib for the treatment of recurrent malignant glioma

May 12, 2021

First patient dosed in pivotal phase II FIREFLY-1 study of DAY-101 in pediatric low-grade glioma

May 12, 2021

AbbVie initiates phase Ib/II trial of ABBV-927 in untreated metastatic pancreatic adenocarcinoma

May 12, 2021

COVID-19 vaccine EXG-5003 enters first-in-human study

May 12, 2021

SARS-CoV-2 vaccines make progress in the young, the old, the in-between

May 11, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...